Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 2.1B | 1.9B | 1.9B |
Cost of revenue | 1.8B | 1.8B | 1.7B | 1.6B |
Gross profit | 298M | 293M | 291M | 271M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 145M | 154M | 140M | 129M |
Other operating expenses | — | 14M | 5M | 1M |
Operating income | 153M | 125M | 146M | 141M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 41M | 44M | 37M | 32M |
Other income expense | 45M | 20M | 25M | 38M |
Pretax income | 157M | 101M | 134M | 147M |
Tax provision | 42M | 23M | 32M | 40M |
Net income | 115M | 78M | 102M | 107M |
Basic EPS | 0.9 | 0.6 | 0.8 | 0.8 |
Diluted EPS | 0.9 | 0.6 | 0.8 | 0.8 |
Basic average shares | 132M | 132.4M | 133M | 134M |
Diluted average shares | 132M | 133M | 133M | 134M |
EBITDA | 239M | 182M | 212M | 214M |
Net income from continuing op. | 115M | 78M | 102M | 107M |
Minority interests | 1M | -2M | -2M | -1M |
Preferred stock dividends | — | — | 0 | 0 |